These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 1976875)

  • 1. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. The RISC Group.
    Lancet; 1990 Oct; 336(8719):827-30. PubMed ID: 1976875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparin during instability in coronary artery disease, Fragmin during Instability in Coronary Artery Disease (FRISC) study group.
    Lancet; 1996 Mar; 347(9001):561-8. PubMed ID: 8596317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of low-molecular-weight heparin with unfractionated heparin acutely and with placebo for 6 weeks in the management of unstable coronary artery disease. Fragmin in unstable coronary artery disease study (FRIC).
    Klein W; Buchwald A; Hillis SE; Monrad S; Sanz G; Turpie AG; van der Meer J; Olaisson E; Undeland S; Ludwig K
    Circulation; 1997 Jul; 96(1):61-8. PubMed ID: 9236418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin (75 mg/day) after an episode of unstable coronary artery disease: long-term effects on the risk for myocardial infarction, occurrence of severe angina and the need for revascularization. Research Group on Instability in Coronary Artery Disease in Southeast Sweden.
    Wallentin LC
    J Am Coll Cardiol; 1991 Dec; 18(7):1587-93. PubMed ID: 1960301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis.
    Oler A; Whooley MA; Oler J; Grady D
    JAMA; 1996 Sep; 276(10):811-5. PubMed ID: 8769591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective comparison of unstable angina versus non-Q wave myocardial infarction during antithrombotic therapy. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Xiong J; Parry G; Adams PC; Chamberlain D; Wieczorek I; Fox KA; McBride R; Chesebro JH; Fuster V
    J Am Coll Cardiol; 1993 Nov; 22(5):1338-43. PubMed ID: 7901254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of heparin, aspirin, or alteplase in reduction of myocardial ischaemia in refractory unstable angina.
    Neri Serneri GG; Gensini GF; Poggesi L; Trotta F; Modesti PA; Boddi M; Ieri A; Margheri M; Casolo GC; Bini M
    Lancet; 1990 Mar; 335(8690):615-8. PubMed ID: 1969013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events Study Group.
    Cohen M; Demers C; Gurfinkel EP; Turpie AG; Fromell GJ; Goodman S; Langer A; Califf RM; Fox KA; Premmereur J; Bigonzi F
    N Engl J Med; 1997 Aug; 337(7):447-52. PubMed ID: 9250846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unstable angina: effect of aspirin and heparin on treatment outcome in hospital patients (a double-blind, placebo-controlled study)].
    Averkov OV; Zateĭshchikov DA; Gratsianskiĭ NA; Logutov IuA; Iavelov IS; Ianus Vm
    Kardiologiia; 1993; 33(5):4-9. PubMed ID: 7967328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction in preventing death and myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group).
    Cohen M; Adams PC; Hawkins L; Bach M; Fuster V
    Am J Cardiol; 1990 Dec; 66(19):1287-92. PubMed ID: 2244556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase plus heparin versus aspirin in unstable angina and non-Q-wave myocardial infarction.
    Schreiber TL; Macina G; McNulty A; Bunnell P; Kikel M; Miller DH; Devereux RB; Tenney R; Cowley M; Zola B
    Am J Cardiol; 1989 Oct; 64(14):840-4. PubMed ID: 2801550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.
    Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators
    N Engl J Med; 1998 May; 338(21):1488-97. PubMed ID: 9599103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective evaluation of a prostacyclin-sparing aspirin formulation and heparin/warfarin in aspirin users with unstable angina or non-Q wave myocardial infarction at rest. The Antithrombotic Therapy in Acute Coronary Syndromes Research Group.
    Cohen M; Parry G; Adams PC; Xiong J; Chamberlain D; Wieczorek I; Fox KA; Kronmal R; Fuster V
    Eur Heart J; 1994 Sep; 15(9):1196-203. PubMed ID: 7982419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin, heparin, or both to treat acute unstable angina.
    Théroux P; Ouimet H; McCans J; Latour JG; Joly P; Lévy G; Pelletier E; Juneau M; Stasiak J; deGuise P
    N Engl J Med; 1988 Oct; 319(17):1105-11. PubMed ID: 3050522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prospective analysis of conservative treatment of acute coronary syndrome].
    Niiazova-Karben ZA; Sidorenko BA; Batyraliev TA; Preobrazhenskiĭ DV; Pershukov IV; Pia IuV; Daniiarov BS
    Kardiologiia; 2002; 42(5):34-7. PubMed ID: 12494146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina.
    Platelet Receptor Inhibition in Ischemic Syndrome Management (PRISM) Study Investigators
    N Engl J Med; 1998 May; 338(21):1498-505. PubMed ID: 9599104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
    Vejar M; Hackett D; Brunelli C; Spallarossa P; Ianetti M; Galassi AR; Lipkin D; Caponnetto S; Patrono C; Maseri A
    Circulation; 1990 Jan; 81(1 Suppl):I4-11; discussion I22-3. PubMed ID: 2403867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy of once daily parnaparin and unfractionated heparin in unstable angina pectoris: PRIME CARE study.
    PRIME CARE Study Investigators Group
    Indian Heart J; 2005; 57(6):648-54. PubMed ID: 16521631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aspirin curbs MIs in unstable angina cases.
    Gunby P
    JAMA; 1983 Jan; 249(1):10-1. PubMed ID: 6336791
    [No Abstract]   [Full Text] [Related]  

  • 20. Eptifibatide and tirofiban: new preparations. Limited benefit.
    Prescrire Int; 2000 Oct; 9(49):135-8. PubMed ID: 11603412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.